This latest combination formulation of four anti-HIV drugs reflects the continuing need for new single and combination treatments for this disease.
Gilead Submits New Drug Application to U.S. FDA for Once-Daily, Single-Tablet “Quad” HIV Regimen
28
OCT
OCT
0
